You are here: Home / Our people / Professor Des Richardson 

Professor Des Richardson

Professor of Cancer Cell Biology/NHMRC Senior Principal Research Fellow
Pathology, School of Medical Sciences
Bosch Institute

D06 - Blackburn Building
The University of Sydney
NSW 2006 Australia

T: +61 2 9036 6548
F: +61 2 9351 3429
E:

Research interests

Professor Richardson’s major contributions to cancer research are focussed on understanding the role of iron in cancer cell proliferation and the development of novel anti-tumour agents known as iron chelators. Indeed, these studies have resulted in highly promising and potent anti-cancer drugs and are subject of a suite of active national patents.

Back to Top

Current national competitive grants*

2012

Pharmacology of potential anti-tumour agents: Iron and copper chelators of the ApT, BpT and DpT classes
Richardson D, Lovejoy D, Brunk U
NHMRC Project Grants ($624,685 over 3 years)

Pre-clinical Development of a Novel Second Generation Chemotherapeutic for Cancer Therapy
Richardson D, Lovejoy D, Mills J
NHMRC Development Grants ($570,000 over 2 years)

Investigating the Cellular Response to Iron-Depletion: The Trilogy of ASK1, Thioredoxin and Ribonucleotide Reductase
Richardson D, Hawkins C, Suryo Rahmanto Y, Lovejoy D, Ponka P
NHMRC Project Grants ($533,675 over 3 years)

2011

Development of iron complexes for the treatment of Friedreich's Ataxia
Richardson D, Ponka P
Muscular Dystrophy Association (USA) Research Support ($450,000 over 3 years)

Development of Iron Complexes for the Treatment of Friedreich?s Ataxia & the Role of Frataxin in Iron Metabolism
Richardson D, Suryo Rahmanto Y, Ponka P
National Health and Medical Research Council Project Grant ($595,048 over 3 years)

2009

Senior Principal Research Fellowship
Richardson D
NHMRC Research Fellowship ($766,250 over 5 years)

* Grants administered through the University of Sydney

Back to Top